Summary: S.2608 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.2608. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (03/22/2018)

Reducing Opioid Risk Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.